CD274 and glioblastoma: A study of the effects of ICI treatment in a mouse sarcoma model also demonstrated immune-activated remodeling of intra-tumoral macrophages43, whereas in preclinical study, a combination of PD-L1 and PD-1 antibodies was effective in the treatment of GBM patients44-46.